Aaron Gorovitz - 21 Oct 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Aaron Gorovitz
Issuer symbol
NRXP
Transactions as of
21 Oct 2022
Net transactions value
$0
Form type
4
Filing time
22 Nov 2022, 16:46:27 UTC
Previous filing
10 Jun 2021
Next filing
11 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRXP Employee Stock Option Award +162,660 162,660 21 Oct 2022 Common Stock 162,660 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the NRx Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan. The options vest on May 25, 2023, generally subject to the Reporting Person's continued service for NRx Pharmaceuticals, Inc.